This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer
Evidence-Based Benefits
ATP resynthesis — skeletal and cardiac muscle have limited pentose phosphate pathway capacity; supplemental ribose provides the sugar backbone for faster ATP rebuilding after severe depletion (Tullson & Terjung, 1991)
Heart failure — Omran et al. (2003) found 5 g ribose three times daily improved diastolic function, exercise tolerance, and quality of life in patients with congestive heart failure
Ischemic heart disease — Pliml et al. (1992) showed ribose improved exercise tolerance and delayed ischemic ECG changes in patients with stable coronary artery disease
Fibromyalgia and CFS — Teitelbaum et al. (2006) pilot study found D-ribose (5 g three times daily) improved energy, sleep, mental clarity, and well-being in fibromyalgia/CFS patients, but the study was open-label and uncontrolled
What the Research Says
D-Ribose is a supplement studied for its potential benefits in various health conditions. Its mechanism of action revolves around ATP resynthesis, particularly in tissues where ATP depletion occurs. However, clinical evidence supporting its use in athletic performance remains limited, as healthy athletes typically do not experience significant ATP depletion during normal training.
In the context of heart failure, several studies have demonstrated promising results. Omran et al. (2003) found that D-ribose improved diastolic function and quality of life in patients with congestive heart failure. Similarly, Pliml et al. (1992) reported beneficial effects on exercise-induced ischemia in patients with stable coronary artery disease. More recent studies have further corroborated these findings. For instance, Petrov et al. (2025) conducted a randomized trial involving 68 heart failure patients and found that multi-ingredient supplementation, including D-ribose, combined with high-intensity training significantly improved exercise capacity, quality of life, and cardiac function compared to ubiquinol-based supplementation.
Additionally, Yu et al. (2024) reviewed 19 randomized clinical trials and concluded that individualized nutrition support, which may include D-ribose, reduces mortality and major cardiovascular events in chronic heart failure patients at high nutritional risk. Pierce et al. (2022) also reported significant improvements in symptoms and cardiac performance in a phase 2 trial of HFpEF patients treated with ubiquinol and/or D-ribose.
Despite these findings, the use of D-ribose in healthy individuals or athletes remains controversial. A systematic review by Song et al. (2022) found that higher doses of D-ribose caused significant cognitive impairment in rodents, potentially due to increased advanced glycation end products (AGEs). This highlights the need for caution and further research into its safety and efficacy across different populations.
In summary, while D-ribose shows promise in improving cardiac function and quality of life in heart failure patients, its role in athletic performance remains underwhelming. Further studies are needed to fully understand its benefits and risks in various clinical settings.
RCTOmran H, Illien S, MacCarter D, et al. (2003). D-Ribose improves diastolic function and quality of life in congestive heart failure patients. European Journal of Heart Failure. DOIPubMed
RCTPliml W, von Arnim T, Stäblein A, et al. (1992). Effects of ribose on exercise-induced ischaemia in stable coronary artery disease. The Lancet. DOIPubMed
ObservationalTeitelbaum JE, Johnson C, St Cyr J (2006). The use of D-ribose in chronic fatigue syndrome and fibromyalgia: a pilot study. Journal of Alternative and Complementary Medicine. DOIPubMed
Song Y, Du Y, An Y, Zheng J, et al. (2022). A systematic review and meta-analysis of cognitive and behavioral tests in rodents treated with different doses of D-ribose.. Frontiers in aging neuroscience. DOIPubMed
Petrov I, Stoichev K, Aliman O, Kashilska Y, et al. (2025). Effects of differing nutritional supplementation combined with high-intensity aerobic interval training on functional exercise capacity, cardiac function, and quality of life in patients with heart failure and reduced ejection fraction: a randomized trial.. American journal of physical medicine & rehabilitation. DOIPubMed
Yu X, Chen Q, Xu Lou I (2024). Dietary strategies and nutritional supplements in the management of heart failure: a systematic review.. Frontiers in nutrition. DOIPubMed
RCTPierce JD, Shen Q, Mahoney DE, Rahman F, et al. (2022). Effects of Ubiquinol and/or D-ribose in Patients With Heart Failure With Preserved Ejection Fraction.. The American journal of cardiology. DOIPubMed
Show 3 more references
Xue Y, Shamp T, Nagana Gowda GA, Crabtree M, et al. (2022). A Combination of Nicotinamide and D-Ribose (RiaGev) Is Safe and Effective to Increase NAD+ Metabolome in Healthy Middle-Aged Adults: A Randomized, Triple-Blind, Placebo-Controlled, Cross-Over Pilot Clinical Trial.. Nutrients. DOIPubMed
Verrilli AM, Leibman NF, Hohenhaus AE, Mosher BA (2021). Safety and efficacy of a ribose-cysteine supplement to increase erythrocyte glutathione concentration in healthy dogs.. American journal of veterinary research. DOIPubMed
RCTCao W, Qiu J, Cai T, Yi L, et al. (2020). Effect of D-ribose supplementation on delayed onset muscle soreness induced by plyometric exercise in college students.. Journal of the International Society of Sports Nutrition. DOIPubMed
